401 related articles for article (PubMed ID: 28527650)
1. New 1-hydroxy-2-thiopyridine derivatives active against both replicating and dormant Mycobacterium tuberculosis.
Salina EG; Ryabova O; Vocat A; Nikonenko B; Cole ST; Makarov V
J Infect Chemother; 2017 Nov; 23(11):794-797. PubMed ID: 28527650
[TBL] [Abstract][Full Text] [Related]
2. New 2-thiopyridines as potential candidates for killing both actively growing and dormant Mycobacterium tuberculosis cells.
Salina E; Ryabova O; Kaprelyants A; Makarov V
Antimicrob Agents Chemother; 2014; 58(1):55-60. PubMed ID: 24126578
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
[TBL] [Abstract][Full Text] [Related]
4. Drug targets in dormant Mycobacterium tuberculosis: can the conquest against tuberculosis become a reality?
Gupta VK; Kumar MM; Singh D; Bisht D; Sharma S
Infect Dis (Lond); 2018 Feb; 50(2):81-94. PubMed ID: 28933243
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel lysine ɛ-aminotransferase inhibitors: An intriguing potential target for latent tuberculosis.
Devi PB; Sridevi JP; Kakan SS; Saxena S; Jeankumar VU; Soni V; Anantaraju HS; Yogeeswari P; Sriram D
Tuberculosis (Edinb); 2015 Dec; 95(6):786-794. PubMed ID: 26299907
[TBL] [Abstract][Full Text] [Related]
6. High-throughput screening of compounds library to identify novel inhibitors against latent Mycobacterium tuberculosis using streptomycin-dependent Mycobacterium tuberculosis 18b strain as a model.
Sharma S; Bhat R; Singh R; Sharma S; Wazir P; Singh PP; Vishwakarma RA; Khan IA
Tuberculosis (Edinb); 2020 Sep; 124():101958. PubMed ID: 32791471
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antimycobacterial activity of some 2-pyridinecarboxyamidrazone derivatives.
Mamolo MG; Vio L; Banfi E; Predominato M; Fabris C; Asaro F
Farmaco; 1992; 47(7-8):1055-66. PubMed ID: 1445613
[TBL] [Abstract][Full Text] [Related]
8. Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design.
Pieroni M; Wan B; Zuliani V; Franzblau SG; Costantino G; Rivara M
Eur J Med Chem; 2015 Jul; 100():44-9. PubMed ID: 26071857
[TBL] [Abstract][Full Text] [Related]
9. Fighting tuberculosis by drugs targeting nonreplicating
Iacobino A; Piccaro G; Giannoni F; Mustazzolu A; Fattorini L
Int J Mycobacteriol; 2017; 6(3):213-221. PubMed ID: 28776518
[TBL] [Abstract][Full Text] [Related]
10. Copper-related toxicity in replicating and dormant Mycobacterium tuberculosis caused by 1-hydroxy-5-R-pyridine-2(1H)-thiones.
Salina EG; Huszár S; Zemanová J; Keruchenko J; Riabova O; Kazakova E; Grigorov A; Azhikina T; Kaprelyants A; Mikušová K; Makarov V
Metallomics; 2018 Jul; 10(7):992-1002. PubMed ID: 29946601
[TBL] [Abstract][Full Text] [Related]
11. Development of 3,5-Dinitrobenzylsulfanyl-1,3,4-oxadiazoles and Thiadiazoles as Selective Antitubercular Agents Active Against Replicating and Nonreplicating Mycobacterium tuberculosis.
Karabanovich G; Zemanová J; Smutný T; Székely R; Šarkan M; Centárová I; Vocat A; Pávková I; Čonka P; Němeček J; Stolaříková J; Vejsová M; Vávrová K; Klimešová V; Hrabálek A; Pávek P; Cole ST; Mikušová K; Roh J
J Med Chem; 2016 Mar; 59(6):2362-80. PubMed ID: 26948407
[TBL] [Abstract][Full Text] [Related]
12. Linked pyridinyl-thiadiazoles: Design and synthesis as potential candidate for treatment of XDR and MDR tuberculosis.
Mahajan NS; Dhawale SC
Eur J Med Chem; 2015 Sep; 102():243-8. PubMed ID: 26280920
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antimycobacterial activity of some 4-pyridinecarboxyamidrazone derivatives.
Mamolo MG; Vio L; Banfi E; Predominato M; Fabris C; Asaro F
Farmaco; 1993 Apr; 48(4):529-38. PubMed ID: 8357468
[TBL] [Abstract][Full Text] [Related]
15. A Novel Small-Molecule Inhibitor of the
Sukheja P; Kumar P; Mittal N; Li SG; Singleton E; Russo R; Perryman AL; Shrestha R; Awasthi D; Husain S; Soteropoulos P; Brukh R; Connell N; Freundlich JS; Alland D
mBio; 2017 Feb; 8(1):. PubMed ID: 28196957
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of 4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran] analogues against both active and dormant Mycobacterium tuberculosis.
Alluri KK; Reshma RS; Suraparaju R; Gottapu S; Sriram D
Bioorg Med Chem; 2018 May; 26(8):1462-1469. PubMed ID: 29501415
[TBL] [Abstract][Full Text] [Related]
17. New Approaches and Therapeutic Options for Mycobacterium tuberculosis in a Dormant State.
Caño-Muñiz S; Anthony R; Niemann S; Alffenaar JC
Clin Microbiol Rev; 2018 Jan; 31(1):. PubMed ID: 29187395
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis.
Lilienkampf A; Mao J; Wan B; Wang Y; Franzblau SG; Kozikowski AP
J Med Chem; 2009 Apr; 52(7):2109-18. PubMed ID: 19271749
[TBL] [Abstract][Full Text] [Related]
19. Selective Killing of Dormant Mycobacterium tuberculosis by Marine Natural Products.
Rodrigues Felix C; Gupta R; Geden S; Roberts J; Winder P; Pomponi SA; Diaz MC; Reed JK; Wright AE; Rohde KH
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28607021
[TBL] [Abstract][Full Text] [Related]
20. Antimycobacterial activity of novel 1-(5-cyclobutyl-1,3-oxazol-2-yl)-3-(sub)phenyl/pyridylthiourea compounds endowed with high activity toward multidrug-resistant Mycobacterium tuberculosis.
Sriram D; Yogeeswari P; Dinakaran M; Thirumurugan R
J Antimicrob Chemother; 2007 Jun; 59(6):1194-6. PubMed ID: 17449482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]